+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years - 65Years
All Genders
Healthy Volunteers
ID06427577

Mechanism Study of ZhenQi FuZheng Granules for Treating Allergic Rhinitis Using Intestinal Flora and Metabolites

Led by The First Affiliated Hospital with Nanjing Medical University · Updated on 2024-12-09

40

Participants Needed

1

Research Sites

156 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the effects of ZhenQi FuZheng granules on allergic rhinitis, a condition involving nasal inflammation. This research combines clinical studies with laboratory experiments on cells and animals to better understand how the treatment may influence intestinal flora and metabolites. The goal is to see if this treatment can improve immune balance and reduce type 2 inflammation in patients with allergic rhinitis. Participants in this study will take ZhenQi FuZheng granules orally, one bag twice a day, for 4 weeks. The study involves collecting biological samples and questionnaires to analyze changes in nasal inflammatory factors and nasal secretions. The research is sponsored by The First Affiliated Hospital with Nanjing Medical University and focuses on linking clinical outcomes with basic scientific research. During the 12 weeks of follow-up, researchers will assess participants using the Rhinoconjunctivitis Quality of Life Questionnaire and a Visual Analog Score for pain to monitor improvements related to allergic rhinitis symptoms. Participants will be monitored for any changes and effects of the treatment during this period, ensuring detailed collection of data on quality of life and pain levels.

CONDITIONS

Brief Title

Study on the Mechanism of ZhenQiFuZheng in the Treatment of Allergic Rhinitis Based on Intestinal Flora and Metabolites

Research Team

L

Lei Cheng

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here